Strategies for Treating Arterial Restenosis Using Polymeric Controlled Release Implants

  • Robert J. Levy
  • Gershon Golomb
  • Joseph Trachy
  • Vinod Labhasetwar
  • David Muller
  • Eric Topol


Coronary artery obstruction is currently being treated with a number of invasive approaches involving catheter based angioplasty procedures. These have included most recently balloon angioplasty combined with expansion of obstructed coronary arteries using balloon expandable stainless steel stents. However, angioplasty itself, especially with stenting, leads to an accelerated reobstruction process, known as restenosis. Research reported in this paper has investigated an approach to preventing restenosis using controlled release drug-polymer implants for local inhibition of the pathophysiologic events of restenosis. Model therapeutic compounds were chosen including aspirin, as an antiplatelet agent, hirulog, as an antithrombin, and colchicine as an antiproliferative. Controlled release polymer matrices were successfully formulated and characterized. Retention of anticoagulant activity for the peptide, hirulog, was demonstrated in vitro. These polymers are suitable for investigations in periadventitial implants and animal models of restenosis. Eventually, controlled release strategies for preventing restenosis will involve integrating of ideal agents including gene therapy, with stents and related devices in order to develop a drug delivery systems approach.


Arterial Wall Control Release Balloon Angioplasty Anticoagulant Activity Constant Release Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    D. W. M. Muller and S. G. Ellis. Coron. Art. Dis., 1, 438 (1990).CrossRefGoogle Scholar
  2. 2.
    D. R. Holmes, R. E. Vliestra, H. C. Smith, et al., Am. J. Cardiol., 53, 77C (1984).PubMedCrossRefGoogle Scholar
  3. 3.
    M. W. Ela, G. S. Roubin and S. B. King., Circulation, 79, 1374 (1989).CrossRefGoogle Scholar
  4. 4.
    R. Ross. N. Engl. J. Med., 314,. 488 (1986).Google Scholar
  5. 5.
    J. H. Ip, V. F. Fuser, L. Badimon, J. Badimon, M. B. Taubman and J. H. Chesebro., J. Am. Coll. Cardiol., 15, 1667 (1990).PubMedCrossRefGoogle Scholar
  6. 6.
    D. W. Muller, S. G. Ellis and E. J. Topol., J. Am. Coll. Cardiol., 19, 418 (1992).PubMedCrossRefGoogle Scholar
  7. 7.
    D. A. Cox, P. G. Anderson, G. S. Roubin, C. Y. Chow, S. K. Agrawal and J. B. Cavender, Circulation, Suppl. II, 84, 71 (1991).Google Scholar
  8. 8.
    M. Ebecke,A. Buchwald, H. Stricker and V. Wiegand, Circulation, Suppl. II, 84, 72 (1991).Google Scholar
  9. 9.
    H. Wolinsky and C. S. Lin, J. Am. Coll. Cardiol., 17, 1748 (1991).CrossRefGoogle Scholar
  10. 10.
    J. R. Spears, K. K. Sourav and L. P. McNath, J. Am. Coll. Cardiol., 17, 179B (1991).PubMedCrossRefGoogle Scholar
  11. 11.
    E. R. Edelman, D. H. Adams and M. J. Karnovsky, Proc. Natl. Acad. Sci. U.S.A., 87, 3773 (199Q).Google Scholar
  12. 12.
    E. R. Edelman, M. A. Nugent, L. T. Smith and M. J. Karnovsky, J. Clin. Invest., 39, 65 (1992).Google Scholar
  13. 13.
    R. J. Levy, T. P. Johnston, A. Sintov and G. Golomb, J. Cont. Rel, 11, 245 (1990).CrossRefGoogle Scholar
  14. 14.
    H. Mond, K. Stokes, J. Holland, L. Griggs, et al., PACE, 11, 214 (1988).PubMedCrossRefGoogle Scholar
  15. 15.
    R. J.Levy, S. F.Bolling, R. Siden, A. Kadish, Y. Pathak, et al, in: “Cosmetic and Pharmaceutical Applications of Polymers” C. G. Gebelein, T. Cheng & V. Yang, Eds., Plenum Publ. Corp., New York, 1991, p. 231.Google Scholar
  16. 16.
    L. Schwartz, M. G. Bourassa, J. Lesperance, et al. N. Engl. J. Med., 318, 1714 (1988).PubMedCrossRefGoogle Scholar
  17. 17.
    J. M. Maraganore, P. Bourdon, J. Jablonski, K. L. Ramachandran and J. W. Fenton, Biochemistry, 29, 7095 (1990).PubMedCrossRefGoogle Scholar
  18. 18.
    D. W. M. Muller, S. G. Ellis and E. J. Topol, J. Am. Coll. Cardiol., 17, 126B (1991).PubMedCrossRefGoogle Scholar
  19. 19.
    S. W. Tam, D. W. Fenton and T. C. Detwiler, J. Biol. Chem., 254, 8723 (1979).PubMedGoogle Scholar
  20. 20.
    R. Schwartz, J. G.Murphy, W. D.Edwards, et al, Circulation, 82, 2190 (1990).Google Scholar
  21. 21.
    J. Gebrane, J. Roland and L. Orcel, Virchow’s Arch. Pathol. Anat., 396, 41 (1982).Google Scholar
  22. 22.
    E. G. Nabel, G. Plautz and G. J. Nabel., Science, 294, 1285 (1990).CrossRefGoogle Scholar
  23. 23.
    D. A. Dichek, R. F. Neville, J. A. Zwibel, et al. Circulation, 80, 1347 (1989).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Robert J. Levy
    • 1
  • Gershon Golomb
    • 2
  • Joseph Trachy
    • 1
  • Vinod Labhasetwar
    • 1
  • David Muller
    • 1
  • Eric Topol
    • 3
  1. 1.The University of Michigan Medical SchoolAnn ArborUSA
  2. 2.School of PharmacyThe Hebrew University of JerusalemJerusalemIsrael
  3. 3.The Cleveland Clinic FoundationClevelandUSA

Personalised recommendations